Trials / Recruiting
RecruitingNCT06295965
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers (CHANCES)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- University of Washington · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is being done to investigate clonal hematopoiesis and therapy-emergent myeloid neoplasms in patients with ovarian or other solid cancers. Researchers want to identify risk factors for developing these blood cancers as well as if there is/are a genetic/environmental component(s) to developing blood cancer.
Detailed description
OUTLINE: This is an observational study. Patients undergo blood sample collection and complete surveys on study. Patients' medical records are also reviewed.
Conditions
- Recurrent Fallopian Tube Carcinoma
- Recurrent Ovarian Carcinoma
- Recurrent Primary Peritoneal Carcinoma
- Recurrent Malignant Solid Neoplasm
- Clonal Cytopenia of Undetermined Significance
- Clonal Hematopoiesis
- Idiopathic Cytopenia of Undetermined Significance
- Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder
- Ovarian Carcinoma
- Myeloid Neoplasm Post Cytotoxic Therapy
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional Study | Non-interventional study |
Timeline
- Start date
- 2024-01-02
- Primary completion
- 2028-12-31
- Completion
- 2031-12-31
- First posted
- 2024-03-06
- Last updated
- 2026-04-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06295965. Inclusion in this directory is not an endorsement.